Activation of the TGF-β Pathway Enhances the Efficacy of Platinum-Based Chemotherapy in Small Cell Lung Cancer Patients

BACKGROUND: Platinum-based chemotherapy is the first choice of treatment for patients diagnosed with small lung cell cancer (SCLC). However, many patients exhibit resistance to it. Therefore, it is imperative to further investigate a prognostic biomarker indicating sensitivity to this therapy. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Anqi, Zhu, Lingxuan, Jiang, Aimin, Mou, Weiming, Zhang, Jian, Luo, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798106/
https://www.ncbi.nlm.nih.gov/pubmed/36590751
http://dx.doi.org/10.1155/2022/8766448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798106/
https://www.ncbi.nlm.nih.gov/pubmed/36590751
http://dx.doi.org/10.1155/2022/8766448

Ejemplares similares